“…Completion of the human genome project revealed the sequences of 865 GPCR genes, and many known signaling molecules (ligands) were found to utilize orphan GPCRs as receptors (Davenport et al, 2013;Fredriksson et al, 2003;Im, 2002Im, , 2004. Several GPCRs have been reported for free fatty acids (FFA) and these were renamed by the International Union of Basic and Clinical Pharmacology Committee on receptor nomenclature and drug classification (NC-IUPHAR), as FFA1, FFA2, FFA3, and FFA4 (formerly known as GPR40, GPR43, GPR41, and GPR120, respectively) (Davenport et al, 2013;Im, 2004Im, , 2013, which recognize and respond to short chain (FFA2 and FFA3), medium long chain (FFA1), and unsaturated long chain fatty acids (FFA4) (Hara et al, 2013;Talukdar et al, 2011). Additionally, GPR84 and GPR119 have also been reported to function as receptors for medium chain fatty acids and fatty acid derivatives, respectively (Im, 2013;Overton et al, 2006;Wang et al, 2006).…”